课题基金 / 基金详情

项目摘要

项目成果

ERIK K FLEMINGTON的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):eb病毒(EBV)在艾滋病相关的非霍奇金淋巴瘤中具有高渗透性,是肿瘤表型的关键驱动因素。虽然EBV潜伏期基因对促进肿瘤表型至关重要,但从潜伏期到裂解周期的转换是EBV感染计划成功的关键方面。因此,推动这种转变的机制多年来一直是积极研究的主题。虽然EBV再激活可以通过刺激b细胞受体(抗ig)或tgf - β受体(异位tgf - β)在组织培养中实现,但尚不确定这种事件在体内EBV感染淋巴细胞中有多常见(David Thorley-Lawson实验室的工作)。这一应用的主要假设是EBV进化出了一种感知机制,潜伏感染的b细胞可以在遇到上皮细胞环境时进行检测。该模型提出,来自口腔/扁桃体上皮的环境信号(例如,在生发中心反应的后期)触发b细胞的再激活,从而促进b细胞到上皮细胞的病毒转移,这是口腔上皮斑块形成和宿主到宿主传播的基本第一步。
英文摘要
DESCRIPTION (provided by applicant): The Epstein-Barr virus (EBV) is highly penetrant in AIDS-associated non-Hodgkin's lymphomas where it is a key driver of the tumor phenotype. While EBV latency genes are critical for facilitating the tumor phenotype, the switch from latency to the lytic cycle is a critical aspect of a successful EBV infection program. As a result, the mechanisms driving this switch have been topics of active investigation over the years. Although EBV reactivation can be achieved in tissue culture through stimulation of the B-cell receptor (with anti-Ig) or the TGF-beta receptor (with ectopic TGF-beta), it is uncertain how common such events are in EBV-infected lymphocytes in vivo (work from David Thorley-Lawson's lab). The overarching hypothesis of this application is that EBV has evolved with a sensing mechanism for latently infected B-cells to detect when they encounter an epithelial cell environment. This model proposes that environmental cues from the oral/tonsil epithelium (in the late stages of the germinal center reaction, for example) trigger reactivation in B-cells, thereby facilitating the B-cell to epithelial cell viral transfer that is a fundamental first step n oral epithelial plaque formation and host- to-host transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
  • 批准号:
    10647826
  • 项目类别:
  • 资助金额:
    $41.28万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference
  • 批准号:
    10548370
  • 项目类别:
  • 资助金额:
    $42.13万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
  • 批准号:
    10580068
  • 项目类别:
  • 资助金额:
    $41.79万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
Programmed splicing derangement as new EBV host cell shut-off mechanism
  • 批准号:
    10446536
  • 项目类别:
  • 资助金额:
    $42.65万
  • 财政年份:
    2022
  • 负责人:
    ERIK K FLEMINGTON
  • 依托单位:
海外基金